Clostridium difficile and the microbiota
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Clostridium difficile infection (CDI) is the leading health care-associated illness. Both human and animal models have demonstrated the importance of the gut microbiota's capability of providing colonization resistance against C. difficile. Risk factors for disease development include antibiotic use, which disrupts the gut microbiota, leading to the loss of colonization resistance and subsequent CDI. Identification of the specific microbes capable of restoring this function remains elusive. Future studies directed at how microbial communities influence the metabolic environment may help elucidate the role of the microbiota in disease development. These findings will improve current biotherapeutics for patients with CDI, particularly those with recurrent disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These concepts of manipulating commensal–pathogen competition for nutrients, such as iron, may also prove relevant to C. difficile infection, where faecal microbial transfer has had therapeutic success through normalization of the commensal microbiota. 149 , 176”
From The battle for iron in enteric infections (2020) · cites this paper as [176]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 3×
“Clostridium cluster XIVa (64, 76): Proteus spp.”
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“Various microbes have also been observed to impact subsets of T cells, such as the induction of Tregs by Clostridium species (57) and Th17 cell differentiation by segmented filamentous bacteria (58).”
BackgroundDethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421 · cited 1×
“Dethlefsen et al. found that although recovery began within weeks of ciprofloxacin cessation, the new community did not necessarily include all community members observed before antibiotic use (36).”
BackgroundDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“although compositional changes may be dependent on the antibiotic used as well as the underlying microbiota community of the individual (34, 35).”
BackgroundReduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · cited 1×
“A decreased diversity of Firmicutes and Bacteroidetes has been observed in the microbiota of IBD patients (50).”
BackgroundLoo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946 · cited 1×
“These increases in CDI burden have occurred in conjunction with the emergence of hyperendemic strains (4, 5).”
BackgroundComposition, variability, and temporal stability of the intestinal microbiota of the elderly
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000097107 · Cited by 1,754 · cited 6×
“Using nonsequencing methods, Hopkins et al. observed that elderly patients with CDI had higher counts of Enterobacteriaceae (Proteobacteria), Enterococcus , and Lactobacillus (both Firmicutes), whereas healthy elderly patients harbored more diverse Bacteroides strains (Bacteroide-table od, fecal microbiota transplanta…”
BackgroundInfluentialThrough Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010667 · Cited by 1,483 · cited 1×
“The human gut microbiome undergoes extreme changes throughout life, and it is not surprising that shifts in the microbial composition have been observed in elderly people (38, 39).”
BackgroundGaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452 · cited 1×
“Various microbes have also been observed to impact subsets of T cells, such as the induction of Tregs by Clostridium species (57) and Th17 cell differentiation by segmented filamentous bacteria (58).”
Background
Research works printed but not linked: 2
- Eyre, 2014, N Engl J Med., 370, 183
- Faber, 2014, Immunol Lett.
Cited by
Host Biology in Light of the Microbiome: Ten Principles of Holobionts and Hologenomes
Bordenstein, S. R., & Theis, K. R. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002226 · Cited by 1,240
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
“Dysbiosis can trigger disease in the first weeks of life as observed in necrotizing enterocolitis [14], during adulthood through the promotion of colorectal cancer [15], or in elderly people as exemplified by Clostridium difficile-associated diarrhea [16].”
BackgroundAntibiotics in early life and obesity
Cox, L. M., & Blaser, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.210 · Cited by 541
Regional Diversity of the Gastrointestinal Microbiome
Martinez-Guryn, K., Leone, V., & Chang, E. B. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.08.011 · Cited by 465
“difficile has been observed at low levels in healthy humans, particularly infants, antibiotic-induced disruption of the indigenous colonic microbiota and resulting increases in colonic primary bile acid concentrations promote its outgrowth, toxin production, and invasion (Seekatz and Young, 2014).”
BackgroundCurrent Sampling Methods for Gut Microbiota: A Call for More Precise Devices
Tang, Q., Jin, G., Wang, G., Liu, T., Liu, X., Wang, B., & Cao, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00151 · Cited by 455
Metadata
- Authors
- Seekatz, A. M., & Young, V. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Young, Vincent B.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-07-18
- Volume
- 124
- Issue
- 10
- Pages
- 4182-4189
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4191019
- OpenAlex
- W2020298266
- Cited by
- 255
- References
- 100
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 15 · 2023: 16 · 2022: 22 · 2021: 17 · 2020: 31 · 2019: 23 · 2018: 28 · 2017: 28 · 2016: 19 · 2015: 13 · 2014: 4
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan (48109)
- National Institutes of Health
- College of Pharmacy, University of Michigan
- Medical School, University of Michigan
- National Institute of Allergy and Infectious Diseases (U19AI090871)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, gut microbiota, colonization resistance, antibiotic-induced dysbiosis, recurrent Clostridium difficile infection, biologic therapy, nosocomial infections
- MeSH terms
- Age Factors, Aged, Animals, Clostridium Infections, Humans, Immune System, Recurrence, Risk Factors, Spores, Bacterial, Clostridioides difficile, Gastrointestinal Tract, Mice, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clostridium difficile and the microbiota. https://app.cochat.ai/papers/10.1172/jci72336
- The paper
- Seekatz, A. M., & Young, V. B. (2014). Clostridium difficile and the microbiota. Journal of Clinical Investigation. https://doi.org/10.1172/jci72336
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.